Financials
- Market Capitalization 9.79 B
- Employee 228
- Founded 2017
- CEO N/A
- Website www.nuvalent.com
- Headquarter Delaware, United States
- FIGI BBG00Z1SLMK5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-17.19
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 893 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 74.11 USD | -3.00% | -14.62% | -0.59% | +89.54% | 10.44 B USD | ||
| 906 | CYTK Cytokinetics, Incorporated - Common Stock | 82.24 USD | -3.10% | -4.47% | +17.23% | +41.55% | 10.23 B USD | ||
| 948 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 56.75 USD | -2.58% | -32.78% | -22.78% | -21.32% | 9.38 B USD | ||
| 959 | CORT Corcept Therapeutics Incorporated - Common Stock | 85.90 USD | -6.51% | -6.98% | +3.61% | +17.08% | 9.22 B USD |